FDA Inspection 1261303 - Azurity Pharmaceuticals, Inc. - February 19, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Azurity Pharmaceuticals, Inc., with an inspection on February 19, 2025, issued by the New England District Office, covering human drugs.

Company: Azurity Pharmaceuticals, Inc.
Inspection Date: February 19, 2025
Product Type: Human Drugs
Office: New England District Office

Open in Dashboard

ID · 5bc3e1cb-551b-4b19-8657-c5a1e0e2c087

Violation Codes1

21 CFR 211.198(a)

Full citation text and observation details available on the Dashboard.